Latest
Subscribe

What 'deep tech' actually means, and why it isn't just another software startup

Deep tech describes ventures built on hard scientific or engineering breakthroughs rather than clever applications of existing digital tools, and understanding the distinction matters for how these companies are funded, regulated and grown.

a person in a blue mask and gloves holding a tablet
Photo · Photo by Toon Lambrechts on Unsplash

A different starting point

The term “deep tech” gets used loosely, often as a synonym for anything technical or futuristic. In practice it has a fairly specific meaning. Deep tech companies are built around a genuine scientific or engineering advance, something that did not previously exist or work reliably, rather than a new way of packaging or distributing existing technology. Think of a startup developing a novel battery chemistry, a quantum computing architecture, a gene-editing technique, or an advanced robotics platform. The core asset is the underlying science or engineering itself, usually protected by patents, deep technical know-how, or years of specialised research.

This contrasts with the classic software startup model, where the technology (cloud computing, mobile apps, payment rails) already exists and is broadly accessible. Those companies compete on business model, user experience, speed of execution and market positioning. A food delivery app or a project management tool does not need a scientific breakthrough to work. It needs good design, reliable engineering and a viable way to acquire customers. Deep tech ventures face that challenge too, but only after clearing a much higher technical bar first.

Longer timelines, different risks

Because deep tech is rooted in unproven science, it typically takes far longer to move from lab to market. A software product can be prototyped in weeks and iterated based on user feedback almost immediately. A new semiconductor material, a fusion energy concept or a novel drug delivery system may need years of research, testing and regulatory approval before anyone can establish whether it works at all, let alone whether people will pay for it.

This changes the nature of risk. Software startups mostly face market risk: will customers want this, and can the company grow fast enough before competitors or costs catch up. Deep tech startups face technical risk on top of that: will the underlying physics, chemistry or biology actually perform as hoped outside a controlled experiment. Many promising ideas fail not because the market rejected them but because the technology could not be scaled reliably or affordably from a small prototype to something manufactured in volume.

This is why deep tech investment tends to require patient capital and specialist expertise. Investors need to understand the science well enough to judge whether a claimed breakthrough is credible, and they need to be comfortable funding companies through long stretches with no revenue while research and testing continue. Universities, national laboratories and government-backed research funding often play a much bigger role here than in consumer software, because so much deep tech originates from academic research rather than a garage or a shared office.

Capital intensity and infrastructure

Deep tech ventures often need physical infrastructure that software startups can skip entirely. Building a prototype battery, a new sensor, or a piece of advanced manufacturing equipment requires laboratories, specialist equipment, materials and skilled scientific staff. This makes deep tech considerably more capital intensive in its early stages. A software team can often reach a working product with modest funding and a small team of engineers. A hardware or materials-science team may need substantial investment before it has anything to demonstrate.

This capital intensity has practical consequences for how these companies grow. Manufacturing partnerships, supply chains and regulatory pathways become central concerns much earlier than they would for a digital-only business. In sectors like clean energy, biotechnology and advanced materials, getting from a working prototype to a product that can be produced reliably at scale is often described as one of the hardest parts of the whole process, sometimes called the transition through pilot and demonstration stages before commercial deployment.

Why the distinction matters

Understanding this divide helps explain why deep tech companies are judged by different milestones than software startups. Progress might be measured by a successful lab trial, a regulatory approval, or a working pilot plant, rather than user growth or monthly revenue. It also explains why deep tech tends to cluster around universities and research institutions, why it depends heavily on specialist technical talent, and why building these companies successfully usually means bridging the gap between rigorous science and the practical demands of a functioning business.